CLINICAL_TRIALS
trial_result
· 2017-02-02
Clinical Trial Update: Study of Potential for Interaction of Fluconazole With F901318 [Phase 1]
Summary
A Phase 1 study completed to assess potential pharmacokinetic interaction between fluconazole and F901318 in invasive aspergillosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: F2G Biotech GmbH | Conditions: Invasive Aspergillosis | Phase 1 | Status: COMPLETED